U.S. drugmaker Pfizer Inc said on Tuesday late-stage study data for its experimental hemophilia therapy showed superiority to the current standard of care treatment in reducing bleeding rates in patients.
Amylyx Pharmaceuticals Inc said on Tuesday that a European regulatory panel had taken a negative view on its amyotrophic lateral sclerosis (ALS) treatment, stalling the company's plans on introducing its first commercial drug in the region.
Japan's Omron will invest 1.28 billion Indian rupees ($15.5 million) in its first medical device factory in India in the southern state of Tamil Nadu, the local government said, the latest foreign manufacturer to set up operations in the region.
Special Report: How doctors buy their way out of trouble
Weight-loss drugs: the next gold rush
How the World Health Organization could fight future pandemics
Seven things to know about bats and pandemic risk
What is APOE4 and how does it relate to Alzheimer's disease?
